Literature DB >> 28458007

Probing the inhibitory activity of epigallocatechin-gallate on toxic aggregates of mutant (L84F) SOD1 protein through geometry based sampling and steered molecular dynamics.

E Srinivasan1, R Rajasekaran2.   

Abstract

Amyloid formation and protein aggregation are considered to be at the core of the disease pathology for the various neurodegenerative disorders such as Amyotrophic lateral sclerosis (ALS). Considerable experimental reports have suggested that epigallocatechin-gallate (EGCG), a natural polyphenol from the green tea inhibits the amyloid formation in multiple neurodegenerative disease. Mutations in SOD1 protein are considered to a key factor that contributes towards the rapid disease progression and the pathogenesis in both, the sporadic and familial form. In our study, we computationally examined the inhibitory action of EGCG against the native and the mutant SOD1 through molecular docking, steered molecular dynamics and conformational sampling methods From the outcome, we could conjecture that the protein destabilization and increased β-sheet propensity that occurred due to mutation were regained upon the binding of EGCG. Moreover, the concepts of the free energy landscape analysis are introduced to establish the visual appearance of protein aggregation upon mutation. Altogether, we come to know that the binding of EGCG on mutant SOD1 has reduced the formation of the toxic aggregates upon mutation. Hence, our study could be an initiative in deciphering the inhibitory action of EGCG against the aggregated mutant SOD1, which could be a therapeutic potential against the treatment for the incurable neurodegenerative disorder (ALS) affecting the mankind.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Conformational sampling; Docking; EGCG; L84F; SOD1

Mesh:

Substances:

Year:  2017        PMID: 28458007     DOI: 10.1016/j.jmgm.2017.04.019

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  10 in total

1.  Computational Investigation on Electrostatic Loop Mutants Instigating Destabilization and Aggregation on Human SOD1 Protein Causing Amyotrophic Lateral Sclerosis.

Authors:  E Srinivasan; R Rajasekaran
Journal:  Protein J       Date:  2019-02       Impact factor: 2.371

Review 2.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

3.  Decoding Conformational Imprint of Convoluted Molecular Interactions Between Prenylflavonoids and Aggregated Amyloid-Beta42 Peptide Causing Alzheimer's Disease.

Authors:  E Srinivasan; G Chandrasekhar; P Chandrasekar; K Anbarasu; A S Vickram; Iftikhar Aslam Tayubi; R Rajasekaran; Rohini Karunakaran
Journal:  Front Chem       Date:  2021-12-20       Impact factor: 5.221

Review 4.  Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation.

Authors:  Anushruti Ashok; Syed Suhail Andrabi; Saffar Mansoor; Youzhi Kuang; Brian K Kwon; Vinod Labhasetwar
Journal:  Antioxidants (Basel)       Date:  2022-02-17

Review 5.  Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update.

Authors:  Roohi Mohi-Ud-Din; Reyaz Hassan Mir; Abdul Jalil Shah; Saba Sabreen; Taha Umair Wani; Mubashir Hussain Masoodi; Esra Küpeli Akkol; Zulfiqar Ali Bhat; Haroon Khan
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

Review 6.  Oxidative Stress in Tauopathies: From Cause to Therapy.

Authors:  Fernando Bartolome; Eva Carro; Carolina Alquezar
Journal:  Antioxidants (Basel)       Date:  2022-07-22

Review 7.  Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies.

Authors:  Shogo Nakano; Shin-Ichi Megro; Tadashi Hase; Takuji Suzuki; Mamoru Isemura; Yoriyuki Nakamura; Sohei Ito
Journal:  Molecules       Date:  2018-08-13       Impact factor: 4.411

8.  The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation.

Authors:  Rebecca Sternke-Hoffmann; Alessia Peduzzo; Najoua Bolakhrif; Rainer Haas; Alexander K Buell
Journal:  Int J Mol Sci       Date:  2020-03-14       Impact factor: 5.923

9.  The Environment Is a Key Factor in Determining the Anti-Amyloid Efficacy of EGCG.

Authors:  Tomas Sneideris; Andrius Sakalauskas; Rebecca Sternke-Hoffmann; Alessia Peduzzo; Mantas Ziaunys; Alexander K Buell; Vytautas Smirnovas
Journal:  Biomolecules       Date:  2019-12-11

10.  Identifying Insulin Fibril Conformational Differences by Thioflavin-T Binding Characteristics.

Authors:  Mantas Ziaunys; Andrius Sakalauskas; Vytautas Smirnovas
Journal:  Biomacromolecules       Date:  2020-11-17       Impact factor: 6.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.